Certified by Founder Lodge
Gedea Biotech AB
Sweden - Lund, Skane
START UP
1 Disclosed Funding Rounds $1,395,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 26 ,2023 | Unknown | $1,395,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
OneChronos | $32,000,000 | (Nov 20, 2024)
Kalder | $10,500,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
RIIG | $3,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
